- Home
- RAPP vs EVCM Comparison
RAPP vs EVCM Comparison
Compare RAPP & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAPP | EVCM |
|---|---|---|
| Founded | 2022 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RAPP | EVCM |
|---|---|---|
| Price | $39.32 | $11.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $48.50 | $10.67 |
| AVG Volume (30 Days) | ★ 290.1K | 98.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.34 | ★ 145.45 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $588,907,000.00 |
| Revenue This Year | N/A | $7.39 |
| Revenue Next Year | N/A | $5.84 |
| P/E Ratio | ★ N/A | $277.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.20 | $7.66 |
| 52 Week High | $42.27 | $14.41 |
Technical Indicators
Market Signals| Indicator | RAPP | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 55.00 |
| Support Level | $25.48 | $10.82 |
| Resistance Level | $41.33 | $12.27 |
| Average True Range (ATR) | 2.08 | 0.66 |
| MACD | 0.18 | 0.12 |
| Stochastic Oscillator | 84.38 | 64.55 |
Price Performance
Historical ComparisonAbout RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.